Plans underway to speed up new biologicals license procedure

The government is considering shortening the period of new biological products in the process of screening their safety and efficacy by introducing the so-called mid-term assessment systemas part of its plan to ensure earlier launching of promising items, according to the Korea Food and Drug Administration (KFDA) on September 21.

The health regulator unveiled its plan to shorten the screenin...